Results 181 to 190 of about 2,601,708 (287)

Biaryl Phosphate-Based Inhibitors of the Transcription Factor STAT4. [PDF]

ChemMedChem
Brovchenko N, Oelsch AM, Protzel C, Berg T.   +3 more
europepmc   +1 more source

Genome-wide identification, characterization and expression analysis of the LIM transcription factor family in quinoa

, 2021
Xiaolin Zhu, Baoqiang Wang, Xian Wang, Chaoyang Zhang, Xiaohong Wei   +4 more
openalex   +2 more sources

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Editorial: Bacterial transcription factors and the cell cycle, volume II

Frontiers in Microbiology, 2023
Morigen, Monika Glinkowska, Jianping Xie, Richa Priyadarshini, Kazutoshi Kasho   +4 more
doaj   +1 more source

Benchmarking large language models for identifying transcription factor regulatory interactions. [PDF]

Bioinformatics
Noel L, Hsiao YW, He Y, Hung A, Cui X, Ray E, Moore JH, Peng PC, Huang X.   +8 more
europepmc   +1 more source

<p>Transcription factor <em>Nrf2</em> induces the up-regulation of lncRNA <em>TUG1</em> to promote progression and adriamycin resistance in urothelial carcinoma of the bladder</p>

, 2019
Zhulei Sun, Gui Huang, Hepeng Cheng
openalex   +2 more sources

AICAR Sustains J1 Mouse Embryonic Stem Cell Self-Renewal and Pluripotency by Regulating Transcription Factor and Epigenetic Modulator Expression [PDF]

, 2013
Xiaoyan Shi, Yongyan Wu, Zhiying Ai, Xin Liu, Liping Yang, Juan Du, Jingjing Shao, Zekun Guo, Yong Zhang   +8 more
openalex   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

REPROGRAMMING ZFP189 TRANSCRIPTION FACTOR FUNCTION REGULATES DRUG SPECIFIC BEHAVIORAL RESPONSES AND TRANSCRIPTION

IBRO Neuroscience Reports, 2023
Joseph Picone, Peter Hamilton, Xiaohong Cui, Natalie Truby, Kijoon Kim, Gabriella Silva   +5 more
doaj   +1 more source

STAN, a computational framework for inferring spatially informed transcription factor activity. [PDF]

Nucleic Acids Res
Zhang L, Sagan A, Qin B, Wang H, Kim E, Hu B, Osmanbeyoglu HU.   +6 more
europepmc   +1 more source